梅花生物:梅花生物2024年年度报告(英文版)

Company Code: 600873 Short name: Meihua Bio
Meihua Holdings Group Co., Ltd.
Annual Report 2024
This is an English translation from the Annual Report 2024, in case of any
inconsistency, the Chinese Version shall prevail.

Important Information
I. The Company’s board of directors, board of supervisors, directors, supervisors, and officers
guarantee that the contents of this annual report are true, accurate, and complete without any false
records, misleading statements, or material omissions and bear joint and several legal liability.
II. All of the Company’s directors have attended the board meeting.
III. Zandar (Shenzhen) CPAs LLP (Special General Partnership) (formerly known as Da Hua
CPAs LLP (Special General Partnership)) has issued an unqualified audit report for the Company.
IV. Wang Aijun, the principal of the Company, Wang Lihong, the accounting principal, and Wang
Ailing, the principal of the accounting body (the accounting officer), hereby declare that they
guarantee the truthfulness, accuracy, and completeness of the financial report in the annual report.
V. Profit distribution plan or capital reserve conversion plan for the Reporting Period as approved
by the Board
Upon deliberation and approval of the 18th meeting of the 10th session of the board of directors, the
profit distribution plan (proposal) for 2024 is as follows: The Company plans to distribute cash dividends
based on the total share capital registered on the equity distribution record date (after deducting shares in
the share repurchase account). A cash dividend of 0.4206 yuan per share (inclusive of tax) will be
distributed to all shareholders. As of December 31, 2024, the Company had a total share capital of
2,852,788,750 shares, based on which the estimated total cash dividend distribution amounts to 1.2 billion
yuan (inclusive of tax).
The plan is yet to be submitted to the general meeting for deliberation. The amount that is actually
distributed will be subject to the notification on equity distribution published by the Company. If there is
any change in the Company’s total share capital before the registration date of equity distribution, the
total amount to be distributed will remain unchanged, and the distribution proportion per share will be
adjusted accordingly.
In November 2024, the Company executed the 2024 interim profit distribution, which was
approved at the Company’s second extraordinary general meeting of 2024. Based on the total share
capital registered on the equity distribution record date (November 21, 2024) of 2,852,788,750 shares,
after deducting 15,589,700 shares in the repurchase account at that time, the total number of shares
participating in the distribution was 2,837,199,050 shares. A cash dividend of 0.17596 yuan per share
(inclusive of tax) was distributed, amounting to a total interim cash dividend of 499,233,544.84 yuan
(inclusive of tax).
In summary, the total cash dividends expected to be distributed by the Company for 2024 amount to
approximately 1,699,116,493.09 yuan (inclusive of tax). Together with 571,185,981.88 yuan used for
share buyback and cancellation in 2024, the total amount represents approximately 83% of the net profit
attributable to shareholders of the listed company for 2024.
VI. Risk Disclosure on Forward-Looking Statements
√ Applicable Not applicable
This annual report involves forward-looking descriptions such as future plans, and such statements do
not constitute material commitments for investors. Investors are reminded to pay attention to the risk of
investment.
VII. Any occupation of funds by the controlling shareholder or other affiliates for non-operating
purposes
No
VIII. Any external guarantee that violates the decision-making procedures
No

IX. Is it the case that more than half of the directors cannot guarantee the truthfulness, accuracy,
and completeness of the annual report disclosed by the Company?
No
X. Warning of Key Risks
For the details of the risks facing the Company, refer to the “Potential Risks” part in “Section 3
Discussion and Analysis by the Management” and the “Risks Related to Financial Instruments” part in
“Section 10 Financial Report”.
XI. Miscellaneous
 Applicable √Not applicable

Contents

Section 1 Definitions......5
Section 2 Company Overview and Key Financial Indicators......9
Section 3 Discussion and Analysis by the Management......13
Section 4 Corporate Governance......51
Section 5 Environmental and Social Responsibility......71
Section 6 Significant Matters......83
Section 7 Share Changes and Shareholders......94
Section 8 Information on Preferred Shares...... 100
Section 9 Information on Securities......100
Section 10 Financial Report......101
Financial statements signed and sealed by the Company’s principal, the accounting principal, and
the